Skip to content
healthcare.dev

ACYCLOVIR

NDC 59651-493, ACYCLOVIR, suspension, from Aurobindo Pharma Limited.

Product NDC
59651-493
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA216331
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59651-493 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ACYCLOVIR200 mg/5mL

Pharmacologic classes

DNA Polymerase Inhibitors [MoA]; Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; Nucleoside Analog [EXT]

Package NDCNDC-11Package
59651-493-4759651049347473 mL in 1 BOTTLE (59651-493-47)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/37761c4f-4378-472e-a41b-6a1d40575cb7

Use it

Look up 59651-493 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59651-493 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59651-493. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.